Abbott G W, Sesti F, Splawski I, Buck M E, Lehmann M H, Timothy K W, Keating M T, Goldstein S A
Department of Pediatrics, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut 06536, USA.
Cell. 1999 Apr 16;97(2):175-87. doi: 10.1016/s0092-8674(00)80728-x.
A novel potassium channel gene has been cloned, characterized, and associated with cardiac arrhythmia. The gene encodes MinK-related peptide 1 (MiRP1), a small integral membrane subunit that assembles with HERG, a pore-forming protein, to alter its function. Unlike channels formed only with HERG, mixed complexes resemble native cardiac IKr channels in their gating, unitary conductance, regulation by potassium, and distinctive biphasic inhibition by the class III antiarrhythmic E-4031. Three missense mutations associated with long QT syndrome and ventricular fibrillation are identified in the gene for MiRP1. Mutants form channels that open slowly and close rapidly, thereby diminishing potassium currents. One variant, associated with clarithromycin-induced arrhythmia, increases channel blockade by the antibiotic. A mechanism for acquired arrhythmia is revealed: genetically based reduction in potassium currents that remains clinically silent until combined with additional stressors.
一个新的钾通道基因已被克隆、鉴定,并与心律失常相关联。该基因编码MinK相关肽1(MiRP1),这是一种小的整合膜亚基,它与形成孔道的蛋白HERG组装在一起,改变其功能。与仅由HERG形成的通道不同,混合复合物在门控、单位电导、钾调节以及III类抗心律失常药物E-4031的独特双相抑制方面类似于天然心脏IKr通道。在MiRP1基因中鉴定出三个与长QT综合征和室颤相关的错义突变。突变体形成的通道开放缓慢且关闭迅速,从而减少钾电流。一种与克拉霉素诱导的心律失常相关的变体增加了抗生素对通道的阻断作用。揭示了一种获得性心律失常的机制:基于基因的钾电流减少在临床上保持沉默,直到与其他应激源结合。